Since the launch of Breast Cancer Awareness initiatives in 1985, more than 517,000 lives have been saved through advances in treatment and proactive screening, according to the American Cancer Society (ACS).
“Today is a day to celebrate forty years of incredible progress in ending cancer as we know it, for everyone,” said Dr. Shanti Sivendran, senior vice president of cancer care support at the ACS and medical oncologist at Penn Medicine, in an interview with ABC News.
>>>Check out Understanding Autism in Adults: Signs, Challenges, and Paths to Diagnosis<<<
How It All Began
In the early 1980s, breast cancer screenings were rare—only about one in four women in the U.S. received mammograms, and access to technology was limited. That changed in October 1985 when the ACS partnered with other organizations to launch a one-week awareness campaign. The initiative quickly gained momentum, and by 1990, President George H. W. Bush proclaimed October as National Breast Cancer Awareness Month.
What started as a modest campaign has grown into a global movement, symbolized by pink ribbons, fundraising walks, and ongoing pushes for earlier detection and innovative treatments.
>>>Check out Noncommunicable diseases<<<
Progress in Screening and Treatment
Today, nearly two-thirds of women in the U.S. undergo regular mammograms—now typically covered by insurance. This widespread access, paired with major treatment advances, has led to a 40% reduction in breast cancer mortality since the 1980s.
The five-year survival rate has climbed from about 75% in the early 1980s to over 90% today. Experts estimate that one-quarter of this progress is due to better screening, while three-quarters stem from breakthroughs in treatment.
“Over the past 40 years, we’ve seen tremendous strides in treatment—from less invasive surgeries and more precise radiation to an explosion of targeted therapies,” said Dr. Katherine Crew, breast medical oncologist at Columbia University’s Irving Medical Center.
Between 2000 and 2023, the U.S. Food and Drug Administration approved over two dozen breast cancer drugs, many designed to target specific tumor biomarkers. These “fingerprints” allow oncologists to personalize treatment, making care more effective and reducing side effects.
>>>More NHS Warns of Long-Term Omeprazole Risks<<<
Addressing Disparities in Care
Despite these advances, not all women have benefited equally. Black women, for example, face significantly higher breast cancer mortality rates compared to white women.
White women have a five-year survival rate of about 93%, while for Black women the figure drops to 84%. For certain aggressive breast cancer subtypes, Black women have up to a 50% higher risk of dying than white women. Experts point to a combination of factors, including access to care, socioeconomic barriers, and biological differences.
“While we’ve made great progress in improving breast cancer outcomes, disparities remain a pressing issue,” Dr. Crew emphasized.
>>>Read About RN to BSN programs in Alabama<<<
Looking Ahead
For Dr. Sivendran, the past four decades highlight the power of awareness, research, and community action. But the fight is far from over.
“Go out there and take action,” she urged. “Get your screening mammogram, understand your risk, invest in cancer research. Together, we can continue making advances over the next 40 years.”
More Health News news.uloscah.com